BioCryst Grants New Hires Stock Options and RSUs as Inducement
BioCryst Pharmaceuticals Inc. has granted stock options and RSUs to four new employees. The options cover 57,100 shares with an exercise price of $7.13, and RSUs cover 46,400 shares. Both will vest in four annual installments starting from the first anniversary of the grant date, December 1, 2025. Each option has a 10-year term.
BioCryst Pharmaceuticals Inc. has granted stock options to purchase a total of 57,100 shares and restricted stock units (RSUs) covering 46,400 shares of common stock to four newly hired employees. The stock options have an exercise price of $7.13 per share, equal to the closing price on the grant date of December 1, 2025. Both the options and RSUs will vest in four equal annual installments starting on the first anniversary of the grant date, provided the employees remain with the company. Each stock option carries a 10-year term. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9596426-en) on December 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
